Sahar Saeed

Assistant Professor

Queen's University

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sahar Saeed is an Assistant Professor at Queen's University, Canada. Her research focuses on public health issues, particularly related to housing stability, cardiometabolic risk profiles in liver disease, and the intersection of HIV and hepatitis C co-infection. She has contributed to several recent articles examining challenges in healthcare access and seroprevalence studies of infectious diseases.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (1)

Helen Faddy

Senior Lecturer

University of the Sunshine Coast

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sahar Saeed

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Sex differences in the prevalence and cardiometabolic risk profiles of steatotic liver disease: A Canadian Longitudinal Study on Aging analysis

Embracing Housing First as a continuum: A response to “Safeguarding against the degradation of Housing First”

Isolation to stabilization: A Housing First approach to address homelessness in Kingston, Ontario

Disengagement from Care Among People Co-Infected with HIV and HCV: A Scoping Review

Frequent Disengagement and Subsequent Mortality Among People With HIV and Hepatitis C in Canada: A Prospective Cohort Study

Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review

Two-Tier Care Pathways for Liver Fibrosis Associated to Non-Alcoholic Fatty Liver Disease in HIV Mono-Infected Patients

An international comparison of anti‐SARS‐COV‐2 assays used for seroprevalence surveys from blood component providers

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard

Evaluation of a pre‐exposure prophylaxis (PrEP)/post‐exposure prophylaxis (PEP) deferral policy among blood donors

Collaborators (1)

Helen Faddy

Make your next move.